Return of fertility after discontinuation of the once-a-month injectable contraceptive cyclofem

Contraception

Volumn 55, Issue 5, 1997, Pages 307-310

  Bahamondes, Luis ^e   Lavín, Pablo ^a   Ojeda, Gabriel ^b   Petta, Carlos ^e   Diaz, Juan ^c   Maradiegue, Eduardo ^d   Monteiro, Ilza ^e  

^a HOSPITAL BARROS LUCO TRUDEAU   (Chile)

^b Profamilia   (Colombia)

^c Population Council   (Brazil)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^e NONE

Author keywords

Cyclofem; Once a month injectable contraceptive; Return of fertility

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; INJECTABLE CONTRACEPTIVE AGENT;

ARTICLE; CLINICAL TRIAL; CONTRACEPTION; COUNSELING; DRUG WITHDRAWAL; FEMALE; FEMALE FERTILITY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY RATE;

AMERICAS; BRAZIL; CHILE; COHORT ANALYSIS; COLOMBIA; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; FAMILY PLANNING; FECUNDITY; FERTILITY; INJECTABLES; LATIN AMERICA; MEDROXYPROGESTERONE ACETATE--PHARMACODYNAMICS; PERU; POPULATION; POPULATION DYNAMICS; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; REVERSIBILITY; SOUTH AMERICA; TIME FACTORS;

ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; ESTRADIOL; FEMALE; FERTILITY; HUMANS; INJECTIONS; MEDROXYPROGESTERONE 17-ACETATE; PREGNANCY; TIME FACTORS;

EID: 0030860791     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00034-6     Document Type: Article

References (12)

1. Newton JR, d'Arcangues C, Hall PE. A review of "once a month" combined injectable contraceptive. J Obstet Gynaecol 1994;14(Suppl 1):S1-34.
2. Hall P, WHO/HRP. The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Contraception 1994;49:489-507.
3. Bassol S, Garza-Flores J. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives. Contraception 1994;49:441-53.
4. Fraser IS, Weisberg E. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Medical J Aust 1981; 1(Spec Suppl 1):1-20.
5. Tietze C, Lewitt S. Evaluation of intrauterine device: ninth progress report of the Cooperative Statistical Program. Stud Fam Plann 1970;1:1-40.
6. Schwallie PC, Assenzo JR. The effect of depo-medroxy-progesterone acetate on pituitary and ovarian function, and the return of fertility after its discontinuation: a review. Contraception 1974;9:181-202.
7. Belhadj H, Sivin I, Diaz S, et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 1986;34:261-7.
8. Nilsson CG. Fertility after discontinuation of levonorgestrel-releasing intrauterine devices. Contraception 1982;25:273-8.
9. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 1992;46:575-84.
10. Zinaman M, Clegg E, Brown C, O'Connor J, Selevan S. Estimates of human fertility and pregnancy loss. Fertil Steril 1996;65:503-9.
11. Bassol S, Garza Flores J, Cravioto MC, et al. Ovarian function following a single administration of depomedroxyprogesterone acetate at different doses. Fertil Steril 1984;42:216-22.
12. Fotherby K, Benagiano G, Toppozada HK, et al. A preliminary pharmacological trial of the monthly injectable contraceptive, Cycloprovera. Contraception 1982;25:261-72.